Christopher Apfelbach, MS, CCC-SLP | |
540 S College Ave Ste 102, Newark, DE 19713-1302 | |
(302) 831-7100 | |
Not Available |
Full Name | Christopher Apfelbach |
---|---|
Gender | Male |
Speciality | Speech-language Pathologist |
Location | 540 S College Ave Ste 102, Newark, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093260481 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | SLP009365 (Georgia) | Secondary |
235Z00000X | Speech-language Pathologist | O1-0001676 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christopher Apfelbach, MS, CCC-SLP 540 S College Ave Ste 102, Newark, DE 19713-1302 Ph: (302) 831-7100 | Christopher Apfelbach, MS, CCC-SLP 540 S College Ave Ste 102, Newark, DE 19713-1302 Ph: (302) 831-7100 |
News Archive
Protein Kinase C (PKC) is a family of enzymes that controls the activity of other proteins in a cell by attaching chemical tags. That simple act helps determine cell survival or death.
Research from Case Western Reserve University School of Dental Medicine to study an isolated agent from common oral bacteria may hold the answer as to how human beta defensins (HBDs)-nature's way of keeping oral microbes from entering the body and wreaking havoc with our health-can be used to create new treatments to block bacteria from entering through the epithelial linings on and in the body.
Research teams at Yale University and the University of Rhode Island have demonstrated a new way to target and potentially treat tumors using a short piece of protein that acts like a nanosyringe to deliver tags or therapy to cells, according to a report in the Proceedings of the National Academy of Sciences.
Stereotaxis, Inc. today reported its financial results for the quarter and the year ended December 31, 2009. Revenue for the recent fourth quarter grew 16% to $14.1 million compared with $12.1 million in the same quarter a year ago.
New evidence reveals the possibility of mood-enhancing effects associated with some flavors, stemming at least in part from natural ingredients bearing a striking chemical similarity to valproic acid, a widely used prescription mood-stabilizing drug, scientists reported here today. This effect joins those previously reported for chocolate, teas and some other known comfort foods.
› Verified 2 days ago
Kate Gordon, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 Brennen Dr, Newark, DE 19713 Phone: 302-292-6021 | |
Emily Randolph, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 630 E Chestnut Hill Rd, Newark, DE 19713 Phone: 302-454-2301 | |
Susan Johnson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 | |
Mary Elizabeth Clarke, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Travertine Way, Newark, DE 19702 Phone: 302-241-5961 | |
Tatiana Guile, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5444 | |
Marielle Schank, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Tyre Ave, Newark, DE 19711 Phone: 302-454-2047 Fax: 302-454-5442 |